BrosMed Artimes™ Pro Received FDA Clearance for Treating Chronic Total Occlusions (CTO) in PTCA Intervention
Release time:
2021-05-24
Guangdong ,China [May 24 , 2021] – Brosmed Co., Ltd. has received a 510(k) clearance from the U.S. Food & Drug Administration for its Artimes™ Pro PTCA balloon catheter.
Guangdong ,China [May 24 , 2021] – BrosMed Co., Ltd. has received a 510(k) clearance from the U.S. Food & Drug Administration for its Artimes™ Pro PTCA balloon catheter.
Artimes™ Pro is a novel PTCA semi-compliant rapid-exchange balloon dilatation catheter manufactured with specific features to facilitate complex coronary interventions. Its soft, laser-welded distal tip—featuring an entry profile of 0.016” for the 1.00 mm and 1.25 mm sizes—favors deep engagement within tight lesions or CTO microchannels, ensuring an smooth, atraumatic entry. Moreover, a novel balloon material ensures a low wrapping profile. The Slider™ hydrophilic coating, a biocompatible and lubricious coating applied from the distal balloon base up to the rapid-exchange port, further improves device trackability across long, tortuous, and calcified lesions. The seamless single-tube transition to the hypotube improves pushability allowing for superior force transmission without any loss during navigation.
These characteristics make the device truly competitive, in terms of penetration power, crossing profile, and pushability, with the best available CTO balloons.
BrosMed Medical is constantly expanding the product portfolio in the field of coronary angioplasty. The Artimes™ (K141025, 1.5-4.0 mm) balloon portfolio has been sold in the United States since 2015 and distributed in more than 50 countries around the world. Artimes™ Pro is a significant new addition to the CTO toolbox for tackling complex lesions in the USA market.
About BrosMed Medical
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
Join Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announces Canadian Approval of RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical today announced Canadian regulatory approval of the RevoEdge™ High-Pressure Cutting Balloon Dilatation Catheter, expanding the company’s presence in North America and marking another milestone in the global commercialization of its specialty coronary portfolio.
2026-09-14
BrosMed Announced CE MDR Approval of VascuGlide™ Microcatheter System
June 15, 2026-BrosMed is pleased to announce that the VascuGlide™ Microcatheter System has received CE MDR certification, marking another significant milestone in the company's commitment to advancing peripheral intervention solutions.
2026-06-18
